AzTrials
AzTrials

Condition

Inflammation Clinical Trials

Studies of inflammation, matched by condition name and medical subject headings. Start with those open to enrolment.

4,174 registered studies

In numbers

Open to volunteers
665
Active
810
With results posted
457
All registered
4,174

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 665
  • Endothelial Dysfunction, Inflammation in Cardiopulmonary and Vascular Disease States

    Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research

    • Recruiting
    • Age: 18 to 100 years
    • Observational study

    Background: This study is designed to provide samples to help us study the genes your blood cells are making as well as the proteins, sugars, fats, vitamins and other metabolites found in your blood or urine.

    Conditions
    Endothelial Dysfunction, Inflammation in Cardiopulmonary and Vascular Disease States, Healthy Volunteers
    Trial name
    NCT03253705
    Where
    United States
    Volunteers
    1,000 people, healthy volunteers welcome
    Sponsor
    National Institutes of Health Clinical Center (CC)
    Can I take part? NCT03253705
  • Urologic Diseases, Male Urogenital Diseases

    Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora

    • Not yet recruiting
    • Age: 18 to 60 years
    • Phase 1

    The primary objective of this clinical trial is to evaluate the safety of autologous engineered corpora cavernosa + albuginea constructs for treatment of complex penile deformities.

    Conditions
    Urologic Diseases, Male Urogenital Diseases, Penile Diseases, Corpus Callosum Malformation
    Trial name
    NCT03463239
    Testing
    Autologous tissue engineered corpora
    Where
    United States
    Volunteers
    10 people
    Sponsor
    Wake Forest University Health Sciences
    Can I take part? NCT03463239
  • Glaucoma, Corneal Transplantation

    Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears)

    • Recruiting
    • Age: 18 years and older
    • Injection or infusion

    Glaucoma is the most common threat to vision rehabilitation in patients with Boston keratoprosthesis type 1 (KPro) implantation.

    Conditions
    Glaucoma, Corneal Transplantation, Inflammation
    Trial name
    AH-Tears (NCT04339907)
    Testing
    Sampling of tears, Sampling of aqueous humor
    Where
    Canada
    Volunteers
    200 people, healthy volunteers welcome
    Sponsor
    Centre hospitalier de l'Université de Montréal (CHUM)
    Can I take part? AH-Tears
  • Schizophrenia

    Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia

    • Recruiting
    • Age: 18 to 65 years
    • Phase 2

    Previous studies found that some NMDA-enhancing agents were able to improve clinical symptoms of patients with chronic schizophrenia.

    Trial name
    NCT04917302
    Testing
    NMDAE plus AIFA
    Where
    Taiwan
    Volunteers
    60 people
    Sponsor
    China Medical University Hospital
    Can I take part? NCT04917302
  • Rheumatoid Arthritis (RA)

    Nutrition in Rheumatoid Arthritis

    • Enrolling by invitation
    • Age: 18 to 85 years

    Background: Individuals with Rheumatoid Arthritis (RA) often experience persistent symptoms such as pain and stiffness despite modern pharmacological treatments. They also have an increased risk of cardiovascular disease.

    Trial name
    NUTRA (NCT06831331)
    Testing
    Healthy diet based on NNR2023, Control/waiting-list
    Where
    Sweden
    Volunteers
    120 people
    Sponsor
    Vastra Gotaland Region
    Can I take part? NUTRA
  • Microvascular Inflammation

    A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

    • Recruiting
    • Age: 18 to 74 years
    • Phase 2
    • Injection or infusion

    In this study, researchers will learn more about a drug called felzartamab in people who have received a kidney transplant and later developed a condition called microvascular inflammation (MVI).

    Trial name
    TRANSPIRE (NCT07219043)
    Testing
    Felzartamab
    Where
    49 sites in United States, Argentina and 9 more
    Volunteers
    81 people
    Sponsor
    Biogen
    Can I take part? TRANSPIRE
  • Inflammatory Bowel Disease, Crohn's Disease

    Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

    • Recruiting
    • Age: 18 to 85 years
    • Observational study

    Background: Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in the digestive tract. Symptoms include stomach pain, diarrhea, and bleeding.

    Conditions
    Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis
    Trial name
    NCT07619547
    Where
    United States
    Volunteers
    100 people
    Sponsor
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Can I take part? NCT07619547
  • COPD (Chronic Obstructive Pulmonary Disease)

    A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

    • Recruiting
    • Age: 40 to 80 years
    • Phase 2
    • Injection or infusion

    This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate - severe chronic obstructive pulmonary disease (COPD).

    Trial name
    Sirius (NCT07646587)
    Testing
    WIN378
    Where
    32 sites in United States, Argentina
    Volunteers
    105 people
    Sponsor
    Windward Bio
    Can I take part? Sirius
  • Inflammation, Depression Disorder

    Inflammatory Pathways Modulated by Prenatal Mindfulness: A Route to Improve Maternal Child Emotional Well Being and Whole Person Health

    • Not yet recruiting
    • Age: 18 to 50 years
    • Lifestyle or therapy programme

    The goal of this study is to investigate inflammation as the biological mechanism by which mindfulness based cognitive therapy for perinatal depression (MBCT-PD) administered during pregnancy improves women's emotional well-being…

    Conditions
    Inflammation, Depression Disorder, Mindfulness, Emotional Well-being
    Trial name
    NCT07892326
    Testing
    Mindfulness-based cognitive therapy for perinatal depression, Pregnancy Health Group
    Where
    United States
    Volunteers
    200 people
    Sponsor
    Oregon Health and Science University
    Can I take part? NCT07892326
  • HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD)

    Reducing Arterial Inflammation Using Eplerenone and Statins in HIV

    • Not yet recruiting
    • Age: 40 to 80 years
    • Phase 2/3
    • Pill or oral medicine

    HIV has transitioned to a chronic disease in which well-treated persons remain at higher risk for heart disease when compared to the general population.

    Conditions
    HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD), Arterial Inflammation, Heart Disease
    Trial name
    SUNRISE HIV (NCT07892664)
    Testing
    Eplerenone
    Where
    2 sites in United States
    Volunteers
    124 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? SUNRISE HIV

Completed, with results posted

All –
  • Atrial Fibrillation, Atrial Flutter

    Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)

    • Completed
    • Age: 55 years and older
    • Phase 3
    • Pill or oral medicine
    • Results posted

    The prevention of perioperative atrial fibrillation (AF) and myocardial injury after non-cardiac surgery (MINS) has the potential to reduce mortality, stroke, and hospital stays in patients undergoing major thoracic surgery.

    Conditions
    Atrial Fibrillation, Atrial Flutter, Myocardial Injury After Non-Cardiac Surgery
    Trial name
    COP-AF (NCT03310125)
    Testing
    Active Colchicine
    Where
    46 sites in United States, Austria and 9 more
    Volunteers
    3,209 people
    Sponsor
    Population Health Research Institute
    Can I take part? COP-AF
  • HIV

    Strength Training and Endurance Exercise for LIFE

    • Completed
    • Age: 50 years and older
    • Results posted

    Research is needed to determine safe and effective exercise rehabilitation programs to prevent and improve physical disability in older adults living with HIV. This problem is of great importance to the VA.

    Trial name
    STEEL (NCT02101060)
    Testing
    exercise
    Where
    2 sites in United States
    Volunteers
    33 people
    Sponsor
    VA Office of Research and Development
    Can I take part? STEEL
  • Inflammation

    Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery

    • Completed
    • Age: 21 years and older
    • Phase 2
    • Results posted

    This is a multicenter, double-masked, randomized, vehicle-controlled, parallel-comparison study conducted at sites in the United States (US) in subjects undergoing routine unilateral cataract extraction and lens replacement…

    Trial name
    NCT06164743
    Testing
    VVN461 Ophthalmic Solution 1.0%, VVN461 Ophthalmic Solution 0.5%, Vehicle
    Where
    10 sites in United States
    Volunteers
    91 people
    Sponsor
    VivaVision Biotech, Inc
    Can I take part? NCT06164743
  • Chronic Kidney Disease, Cardiovascular Disease

    Management of Cardiovascular Disease in Kidney Disease (MaCK) Study

    • Completed
    • Age: 18 to 80 years
    • Phase 2
    • Surgery or procedure
    • Results posted

    Cardiovascular disease (CVD) is the largest concerns for patients with Chronic kidney disease (CKD). At present time the investigators do not have proven effective strategies to reduce high CVD related deaths in CKD.

    Conditions
    Chronic Kidney Disease, Cardiovascular Disease, Inflammation, Atherosclerosis
    Trial name
    MaCK (NCT03636152)
    Testing
    MRI carotid, APWV, Hydroxychloroquine
    Where
    United States
    Volunteers
    100 people
    Sponsor
    VA Office of Research and Development
    Can I take part? MaCK
  • Burn

    Vitamin E Supplementation in Burned Patients

    • Completed
    • Age: 16 to 85 years
    • Phase 2/3
    • Pill or oral medicine
    • Results posted

    A dietary antioxidant, alpha-tocopherol, will be used to potentially attenuate Vitamin E short- and long-term losses in plasma and adipose, reverse the oxidative stress of burn injury and, in the process, decrease the secondary…

    Trial name
    NCT01749371
    Testing
    Vitamin E
    Where
    3 sites in United States
    Volunteers
    27 people
    Sponsor
    The University of Texas Medical Branch, Galveston
    Can I take part? NCT01749371

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in